Nasdaq: TTRX
Turn Therapeutics insiders
The officers, directors and 10% owners of Turn Therapeutics Inc. who hold the most stock, valued at the live TTRX price.
$8.64
TTRX today −$250K (−2.81%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their TTRX stock
- $149M
- Market value
- $264M
- Held by ranked insiders
- 56.3%
Insiders by value of TTRX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Bradley Burnam | Chief Executive Officer | 15,416,260 | $133M | 50.4% | 1210th |
| 2 | Abraham Chesed | Insider | 1,447,268 | $12.5M | 4.73% | 7413th |
| 3 | Arthur Golden | Director | 360,602 | $3.1M | 1.18% | 5520th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Turn Therapeutics; see each profile for the filing.